New York State Common Retirement Fund Immunic, Inc. Transaction History

New York State Common Retirement Fund

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$3.13 - $12.25 $30,918 - $121,005	-9,878 Reduced 98.45%	156 $1,000
Q1 2022 May 05, 2022	SELL	$9.54 - $14.26 $104 - $156	-11 Reduced 0.11%	10,034 $113,000
Q3 2021 Nov 02, 2021	SELL	$8.05 - $13.29 $26,548 - $43,830	-3,298 Reduced 24.72%	10,045 $89,000
Q2 2021 Aug 02, 2021	BUY	$11.76 - $16.85 $115,753 - $165,854	9,843 Added 281.23%	13,343 $164,000
Q1 2021 May 11, 2021	SELL	$14.21 - $25.3 $55,419 - $98,670	-3,900 Reduced 52.7%	3,500 $56,000
Q4 2020 Feb 08, 2021	BUY	$14.8 - $20.37 $82,880 - $114,072	5,600 Added 311.11%	7,400 $113,000
Q3 2020 Nov 05, 2020	SELL	$11.74 - $22.0 $54,004 - $101,200	-4,600 Reduced 71.88%	1,800 $33,000
Q2 2020 Aug 07, 2020	BUY	$5.67 - $15.86 $36,288 - $101,504	6,400 New	6,400 $78,000

56.3M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $30.3M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.